Researchers Find Blood Marker that Defines Which Patients Will Respond to Colorectal Cancer Drug (VIDEO)
Caption
Researchers at the Princess Margaret Cancer Centre have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.
Credit
UHN
Usage Restrictions
Credit UHN
License
Licensed content